Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1379 Engineered toxin body targeting TIGIT depletes Tregs in the tumor microenvironment and reduces tumor burden in mice
Compose a Response to This Article
Other responses
No responses have been published for this article.